Early Access to Tafamidis for Patients With Transthyretin Amyloid Cardiomyopathy | JACC: Advances

JACC Specialty Journals
22/10/2025 2 min
Early Access to Tafamidis for Patients With Transthyretin Amyloid Cardiomyopathy | JACC: Advances

Listen "Early Access to Tafamidis for Patients With Transthyretin Amyloid Cardiomyopathy | JACC: Advances"

Descargar episodio Ver en sitio original

Episode Synopsis

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Early Access to Tafamidis for Patients With Transthyretin Amyloid Cardiomyopathy.

More episodes of the podcast JACC Specialty Journals

The Effect of Atrial Fibrillation Burden on Quality of Life: Sub-analysis of the SHAM-PVI Trial | JACC: Clinical Electrophysiology 07/11/2025
Outcomes of Left Atrial Appendage Occlusion in Patients With and Without Gastrointestinal Bleeds | JACC: Clinical Electrophysiology 07/11/2025
Risk Stratification in LBBB after TAVI: Comparison Between a Novel ECG Algorithm and ESC Criteria | JACC: Clinical Electrophysiology 07/11/2025
Mental Disorders Following Implantable Cardioverter-Defibrillator Therapy: Incidence and Prognostic Implications in a Nationwide Cohort Study | JACC: Clinical Electrophysiology 07/11/2025
Electrode Thermal Profile During Ventricular RF Ablation: A novel indication to potentially inform energy delivery | JACC: Clinical Electrophysiology 07/11/2025
Prevalence of Peridevice Leak in Patients With Left Atrial Appendage-Occlusion vs Without Electrically Isolated Left Atrial Appendage | JACC: Clinical Electrophysiology 07/11/2025
Impact of Device Compression on Peridevice Leak After Left Atrial Appendage Closure: The Impression LAAC Study | JACC: Clinical Electrophysiology 07/11/2025
Atrial Fibrillation Detected by Handheld ECG and Ischemic Stroke Risk in a 55- to 64-Year-Old Chinese Population | JACC: Asia 04/11/2025
Bleeding Outcomes of Ticagrelor Versus Clopidogrel in Acute Coronary Syndrome Patients: A Multiethnic Database Study | JACC: Asia 04/11/2025
CYP2C19 Polymorphism and Clopidogrel Efficacy in Long-Term Outcomes of Large-Artery Atherosclerotic Stroke: The NCVC Genome Registry | JACC: Asia 04/11/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA